Home > Products > Biosimilars

BioSIM anti-Human CD14 Antibody (Atibuclimab Biosimilar), Research Grade

Catalog: SIM0062
Cost advantage to: SIM0061
Isotype: IgG4-kappa
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic biosimilar has the same variable regions as Atibuclimab (a chimeric mAb with murine variable regions and human IgG4 Fc), ideal for research. It targets CD14 (a key innate immune PAMP-detecting receptor, LPS co-receptor, expressed on monocytes/macrophages), blocks CD14-LPS interaction to reduce TLR4 activation and inflammation, fitting for studying CD14 signaling, innate immunity, etc.
 

Specifications

Product Name BioSIM anti-Human CD14 Antibody (Atibuclimab Biosimilar), Research Grade
Size 1mg/5mg
Isotype IgG4-kappa
Target CD14
Other Names 28C5, termedIC14, CAS: 2417175-94-9
CAS 2417175-94-9
Reactivity Human
Host Species Chimeric
Background This non-therapeutic biosimilar has the same variable regions as Atibuclimab (a chimeric mAb with murine variable regions and human IgG4 Fc), ideal for research. It targets CD14 (a key innate immune PAMP-detecting receptor, LPS co-receptor, expressed on monocytes/macrophages), blocks CD14-LPS interaction to reduce TLR4 activation and inflammation, fitting for studying CD14 signaling, innate immunity, etc.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products